Biden administration amps up pressure on US Senate over nomination delays

By Patricia Zengerle and Simon Lewis WASHINGTON (Reuters) – U.S. Secretary of State Antony Blinken said on Monday that a Senate delay in confirming President Joe Biden’s nominees for diplomatic positions was undermining national security, echoing similar concerns from defense officials on delays to military promotions. Blinken told reporters that he had sent a letter…

Read More

US stocks rise on earnings outlook, global shares dip on China data

By Herbert Lash NEW YORK (Reuters) -U.S. stocks rose on Monday on expectations corporate earnings will exceed forecasts, but global shares and the dollar traded little changed after data showed the Chinese economy grew slower than anticipated. China overnight reported growth of 0.8% in the second quarter, above the 0.5% forecast, but the annual pace…

Read More

End of Black Sea grains deal promises pain for Africa’s neediest

By Abdi Sheikh and Aaron Ross MOGADISHU (Reuters) – Russia’s announcement that it was withdrawing from a pact that allowed Ukrainian grains to leave Black Sea ports sent a shiver through poorer countries, many of which are already reeling from inflation, climate shocks and conflict. The Black Sea grains deal, brokered by the United Nations…

Read More

China slams planned US visit of ‘separatist’ Taiwan presidential front-runner

By Liz Lee and Ben Blanchard BEIJING/TAIPEI (Reuters) -China reacted with anger on Monday to a planned visit next month to the United States by “separatist” Taiwan presidential frontrunner Vice President William Lai, as the government in Taipei said it saw no reason to overreact to mere transit stops. Taiwanese presidents and vice presidents traditionally…

Read More

US securities regulator ‘disappointed’ with defeat over Ripple’s XRP

WASHINGTON (Reuters) -The head of the U.S. securities regulator said Monday the agency was “disappointed” with a judge’s recent ruling that Ripple Labs Inc did not violate federal securities laws in a major blow to its efforts to rein in the cryptocurrency sector. U.S. Securities and Exchange Commission Chair Gary Gensler said his agency was…

Read More

US FDA approves Sanofi-AstraZeneca’s preventive RSV therapy for babies

(Reuters) -The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi and partner AstraZeneca’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers. The therapy, branded Beyfortus, was approved for preventing lower respiratory tract disease in infants born during or entering their first RSV season, and in children…

Read More